Board Meeting On 14.09.2017
Pursuant to Regulation 29 (1) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform you that the meeting of the Board of Directors of the Company will be held on Thursday, the 14th day of September, 2017 at the Registered Office of the Company at 16, Community Centre, First Floor, Saket, New Delhi - 110017, inter-alia to consider and approve the Unaudited Financial Results for the quarter ended on 30th June, 2017. AGM On 29.09.2017
Dear Sir, This is to inform you that the TWENTY SEVENTH ANNUAL GENERAL MEETING of the members of 'KOTHARI FERMENTATION AND BIOCHEM LIMITED' will be held on Friday, the 29th day of September, 2017 at 11:00 A.M. at 'Bipin Chandra Pal Memorial Trust Auditorium', Satindra Mohandev Charitable Medical Centre, A-81, Chittranjan Park, New Delhi-110019.... Board Meeting Postponed
Pursuant to Regulation 29 (1) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 and further to the earlier letter dated 8th August, 2017 conveying the intimation of the meeting of the Board of Directors of the Company which was scheduled to be held on Monday, the 14th day of August 2017 inter-alia to consider and approve the Unaudited Financial Results for the quarter ended on 30th June, 2017, will be considered in the Board... Notice Of Board Meeting And Closure Of Trading Window.
Pursuant to Regulation 29 (1) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform you that the meeting of the Board of Directors of the Company will be held on Monday, the 14th day of August 2017 at the Registered Office of the Company at 16, Community Centre, First Floor, Saket, New Delhi 110017, inter-alia to consider and approve the Unaudited Financial Results for the quarter ended on 30th June, 2017.... Shareholding for the Period Ended June 30, 2017
Kothari Fermentation & Biochem Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here Financial Statements As Per New Format With Reference To Your Email.
Kind Attention: Mr. Rakesh Parekh Sub: Your email dated 10/07/2017 Dear Sir As per your abovementioned email , we are enclosing herewith financial result quarter ended / year ended 31/03/2017 in prescribed format as per SEBI circular Ref. CIR/CFD/FAC/62/2016 dated July 05, 2016 (Point 2.1 and 2.4 ) - ( Standalone Result ). Please take on record. (Kavita Tanwar) Company Secretary Statement Of Deviation Or Variation Under Regulation 32(1) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended June 30, 2017.
We are enclosing herewith Statement of Deviation or Variation in Public Issue, Rights Issue, Preferential Issue etc under Regulation 32(1) Of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter ended 30.06.2017. Though the same is not applicable to our Company, as there was no Rights Issue, Preferential Issue etc during the quarter ended 30.06.2017, yet the same is filed for your information and record.... Submission Of Grievance Redressal Mechanism Under Regulation 13(3) Of SEBI (Listing Obligations & Disclosure Requirements) For The Quarter Ended 30Th June, 2017.
Please find the attached Quarterly Compliance Status of Investor Complaints for the Quarter ended 30th June, 2017. Kindly take the above on your record. Audited Financial Results For The Quarter And Financial Year Ended 31St March 2017.
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors at their Meeting held on 30th May, 2017 considered and approved, interalia, the Audited Financial Results along with Audit report of the Company for the fourth quarter and year ended on 31st March, 2017....